Redeye updates its estimates and fair value range following Dala Energi’s Q4 report last week.
HydrogenPro (“HydrogenPro” or “the Company”) is a leader in the green hydrogen space with the world’...
Redeye comments on BioInvent's fourth-quarter report 2024.
Med en välfylld kassa efter en framgångsrik emission, flera pågående dialoger med möjliga samarbetsp...
Redeye gives its initial comments on the Q4 2024 report from Scandinavian ChemoTech, which was mostl...
Redeye updates on Northbaze Group following its Q4 results, which were weaker than expected in terms...
Redeye is making rather small changes to its forecasts following the Q4 report.
Refine Group AB (”Refine”, ”Koncernen” eller ”Bolaget”) är en varumärkesgrupp med ett digitalt fokus...
Redeye returns with an updated view of Saniona following the Q4 report and recent events in the comp...
Redeye provides a research update following MindArk’s softer-than-expected Q4 report.
Acquires US technology company Sounding Board Adds 2.
ODI Pharma AB (“ODI Pharma” or the ”Company”) published on February 27th the company’s Q2-report for...
Q-linea has improved access to growth capital and recently advanced the ASTar launch in Europe and t...
Redeye leaves its initial comments on Integrum’s Q3 report.
Svag försäljning men förbättrad lönsamhet Nettoomsättningen minskade med 19,9 procent, främst på gru...
